Diabetes drug Actos linked to bladder cancer risk

The FDA has updated the drug label for Actos, which is usually prescribed to treat Type 2 diabetes. The new label states the use of the drug for more than one year may be associated with an increased risk of bladder cancer.

If you or a loved one has taken Actos you may have a claim.

Free Consultation Form

Please fill out this short form so we'll have the information we need to contact you about these or any other legal concerns you may have. We look forward to working with you, and hope that we can help you get the justice you deserve.

Important Actos Facts

Between 2004 and 2009 more than 500,000 adverse reactions to anti-diabetic drugs were reported
Among the above cases, 138 instances of bladder cancer were identified
Of the 138 bladder cancer patients, 1/5 were taking Actos (source: Reuters)
Actos is in the same class of drugs as GlaxoSmithKline's Avandia, which has not been associated with bladder cancer but has been linked to heart risks.